No .
From the clinical trial info site about the Phase 3 Crohn's Disease trial;
https://clinicaltrials.gov/ct2/show/NCT00482092
Column 1 Column 2 0 Estimated Primary Completion Date : July 2018 1 Estimated Study Completion Date : July 2020
Some time during July 2018 it is thought the final Primary measure will be taken from the last person enrolled in the trial which is, are they in remission i.e. are they cured of Crohn's Disease at least for the time being as per the Primary outcome measure. We should be told the outcome of the Primary and Secondary measures in a month or two after July 2018.
The Phase 3 trial does not finish until around July 2020, my guess is to see how long the treatment lasts for. Do the effects last for at least 2 years, or less, will any re-treatment be necessary.
So we wait, unless the FDA changes the rules about how much needs to be known over the following years before release could be considered.
- Forums
- ASX - By Stock
- Ann: MSB Clinical Program Update For MPC-150-IM In Heart Failure
No :(. From the clinical trial info site about the Phase 3...
- There are more pages in this discussion • 70 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
55.5¢ |
Change
0.060(12.1%) |
Mkt cap ! $633.0M |
Open | High | Low | Value | Volume |
50.0¢ | 59.0¢ | 48.5¢ | $16.88M | 30.80M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 62700 | 55.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
56.0¢ | 40000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 62700 | 0.555 |
11 | 117118 | 0.550 |
4 | 40314 | 0.545 |
9 | 197656 | 0.540 |
2 | 25000 | 0.530 |
Price($) | Vol. | No. |
---|---|---|
0.560 | 40000 | 1 |
0.565 | 310 | 1 |
0.570 | 58775 | 2 |
0.575 | 43000 | 3 |
0.580 | 76419 | 3 |
Last trade - 16.10pm 29/03/2024 (20 minute delay) ? |
|
|||||
Last
55.5¢ |
  |
Change
0.060 ( 15.7 %) |
|||
Open | High | Low | Volume | ||
50.5¢ | 59.0¢ | 48.5¢ | 11524458 | ||
Last updated 16.02pm 29/03/2024 ? |
Featured News
MSB (ASX) Chart |
The Watchlist
BGD
BARTON GOLD HOLDINGS LIMITED
Alex Scanlon, Managing Director & CEO
Alex Scanlon
Managing Director & CEO
SPONSORED BY The Market Online